Kinnevik:Interim Report 1 January - 30 June 2019
”It was an eventful second quarter, during which we focused our efforts on continuing the shift in our portfolio towards growth companies. These efforts included supporting high-performers in our private portfolio, evaluating our Millicom stake and supporting the IPO of Global Fashion Group.”
Georgi Ganev, CEO of Kinnevik
KEY PORTFOLIO DEVELOPMENTS
- Global Fashion Group began trading on the Frankfurt Stock Exchange on 2 July. The company raised a total of c. EUR 200m, of which EUR 60m from Kinnevik, to fuel continued growth
- Livongo announced its intention to go public at a proposed price range corresponding to a fully diluted pre-money valuation of USD 2.1-2.4bn. Kinnevik has agreed to purchase additional shares at the IPO price from one of Livongo’s investors, and we have also indicated our interest in purchasing newly issued shares in the IPO
INVESTMENT MANAGEMENT ACTIVITIES
- Total investments of SEK 1,367m during the quarter, whereof SEK 632m in GFG, SEK 336m in Kolonial, SEK 156m in Monese, SEK 85m in Pleo and SEK 157m in other existing assets
- During the quarter Kinnevik announced an intention to divest and distribute the shareholding in Millicom. While the two-step divestment could not be concluded at terms we found agreeable, Kinnevik remains firmly committed to continuing to strengthen our financial position and evolve the portfolio towards a higher proportion of growth companies. Consequently, we continue to evaluate potential next steps in relation to our shareholding in Millicom
- Net asset value of SEK 89.0bn (SEK 323 per share), up SEK 4.7bn or 6% during the quarter, primarily driven by positive share price development in Zalando and Tele2, furthered by upwards revisions of the fair values of both Livongo and Babylon, partially offset by the decline in value of Global Fashion Group
- Net debt position increased by SEK 1.7bn to SEK 5.7bn, resulting in leverage of 6.0% of Portfolio Value
A conference call will be held today, 19 July 2019, at 10.00 CET to present the results.
The presentation will be held in English and also be made available via audiocast on Kinnevik’s website, www.kinnevik.com.
Link to the audiocast: https://edge.media-server.com/m6/p/wyhqdzwo
Those who wish to participate in the conference call are welcome to dial-in on the below numbers. To ensure that you are connected to the conference call, please dial in and register your attendance a few minutes before the conference call begins.
UK: +44 3333000804
SE: +46 856642651
US: +1 6319131422
Confirmation code: 73808843#
This information is information that Kinnevik AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 08.00 CET on 19 July 2019.
For further information, visit www.kinnevik.com or contact:
Torun Litzén, Director Corporate Communications
Phone +46 (0)70 762 00 50
Kinnevik is an industry focused investment company with an entrepreneurial spirit. Our purpose is to build digital businesses that provide more and better choice. We do this by working in partnership with talented founders and management teams to create, develop and invest in fast growing businesses in developed and emerging markets. We believe in delivering both shareholder and social value by building companies that contribute positively to society. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik's shares are listed on Nasdaq Stockholm's list for large cap companies under the ticker codes KINV A and KINV B.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Sista dag för handel med BTA B i Oboya6.12.2019 13:14:00 CET | Pressemelding
Oboya Horticulture Industries AB: s (” Oboya” eller” Bolaget”) företrädesemission har registrerats vid Bolagsverket. Sista dag för handel i Bolagets betalda tecknade aktier, OBOYA BTA B, är den 11 december 2019. Stoppdag hos Euroclear för växling från BTA till aktier är den 13 december 2019. De nya aktierna beräknas bokas ut på respektive aktieägares VP-konto/depå den 17 december 2019. Efter registrering av företrädesemissionen och den kvittningsemission som offentliggjordes den 25 november 2019 uppgår Oboyas aktiekapital till 1 256 175,08 SEK och antalet B-aktier till 34 485 918. Rådgivare Augment Partners AB är finansiell rådgivare och Hamilton Advokatbyrå KB är legal rådgivare till Oboya i samband med Företrädesemissionen. Aqurat Fondkommission AB agerar emissionsinstitut. För mer information, vänligen kontakta: Robert Wu, VD Oboya Horticulture Industries AB (publ) Tel: + 86 159 6983 5999 E-post: email@example.com Hemsida: www.oboya.se Erik Penser Bank AB är Oboyas Certified Advise
Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 20206.12.2019 12:45:00 CET | Press release
DUBLIN, Dec. 06, 2019 (GLOBE NEWSWIRE) -- The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2020 third quarter cash dividend of $0.54 per ordinary share, representing an 8 percent increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in June 2019. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 42 consecutive years. The dividend is payable on January 17, 2020, to shareholders of record at the close of business on December 27, 2019. About Medtronic Medtronic plc ( www.medtronic.com ), headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 count
Oasmias företrädesemission övertecknad6.12.2019 12:25:00 CET | Pressemelding
Det preliminära utfallet i företrädesemissionen i Oasmia Pharmaceutical AB (publ) (”Oasmia” eller “Bolaget”), vars teckningsperiod avslutades den 4 december 2019, visar att 198 329 980 aktier tecknats i företrädesemissionen med stöd av teckningsrätter, vilket motsvarar cirka 99,5 procent av företrädesemissionen. Därutöver har Bolaget mottagit anmälningar om att teckna 78 277 041 aktier utan stöd av teckningsrätter, vilket motsvarar cirka 39,3 procent av företrädesemissionen. Företrädesemissionen är därmed övertecknad. ”Jag är mycket nöjd med utfallet i företrädesemissionen samt är tacksam för det stöd vi fått från våra aktieägare. Jag är imponerad av Oasmias ledningsgrupps prestationer, då de under press visat marknaden deras förmåga att utveckla Oasmia till en kommersiell organisation med en spännande framtida agenda”, kommenterar styrelseordförande Jörgen Olsson. Det preliminära utfallet i Oasmias företrädesemission, vars teckningsperiod löpte från och med den 20 november 2019 till o
Oasmia’s rights issue has been oversubscribed6.12.2019 12:25:00 CET | Press release
The preliminary result of the rights issue in Oasmia Pharmaceutical AB (publ) (”Oasmia” or the “Company”), in which the subscription period ended on 4 December 2019, amounts to 198,329,980 shares subscribed for in the rights issue with subscription rights, which corresponds to approximately 99.5 percent of the rights issue. In addition, the Company has received applications to subscribe for 78,277,041 shares without subscription rights, corresponding to approximately 39.3 percent of the rights issue. Thus, the rights issue has been oversubscribed. “I am very pleased with the outcome in the rights issue, and grateful for the support from our shareholders. I’m impressed by the Oasmia team’s performance to, under pressure, show the market their determination to transform Oasmia into a commercial entity with a thrilling agenda going forward”, comments Jörgen Olsson, Chairman of the Board. The preliminary result of the rights issue in Oasmia, in which the subscription period took place from
Result of Riksbank reversed auctions SEK bonds6.12.2019 10:07:00 CET | Press release
Auction date 2019-12-06 Loan 3109 Coupon 1.00 % ISIN-code SE0005703550 Maturity 2025-06-01 Tendered volume, SEK mln 250 +/- 250 Volume offered, SEK mln 750 Volume bought, SEK mln 250 Number of bids 5 Number of accepted bids 2 Average yield -1.917 % Lowest accepted yield -1.929 % Highest yield -1.899 % % accepted at lowest yield 60.00 Auction date 2019-12-06 Loan 3113 Coupon 0.125 % ISIN-code SE0009548704 Maturity 2027-12-01 Tendered volume, SEK mln 250 +/- 250 Volume offered, SEK mln 450 Volume bought, SEK mln 250 Number of bids 4 Number of accepted bids 1 Average yield -1.855 % Lowest accepted yield -1.855 % Highest yield -1.855 % % accepted at lowest yield 100.00
ASM INTERNATIONAL TO HOST TECHNOLOGY SEMINAR6.12.2019 10:00:00 CET | Press release
Almere, The Netherlands December 6, 2019 ASM International N.V. (Euronext Amsterdam: ASM) today announces that it will host a technical luncheon seminar in San Francisco, CA, US, on Wednesday, December 11, 2019, the third day of the IEDM Conference. At this technology seminar, ASM will highlight the challenges and potential solutions for metallization applications. The agenda is as follows: 11:30 am Reception, food and drinks 12:00 - 12:15 pm Welcome and introduction 12:15 - 1:00 pm Invited speaker: Dr. Raghuveer Makala (Western Digital) - "Metallization Challenges in 3D NAND Flash" Following the presentations, there is an opportunity for open discussion and networking until 1:15 pm. The ASM technology seminar will take place in the Golden Gate room (25th floor) at the Nikko Hotel (across from the Hilton San Francisco), San Francisco, CA 94102. The room will open at 11:30 am for invited attendees. Interested parties should contact Rosanne de Vries, +31 88 100 8569, Rosanne.de.Vries@asm